World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 13 January 2020
Main ID:  ACTRN12614001037695
Date of registration: 25/09/2014
Prospective Registration: No
Primary sponsor: Invicta s. z o.o.
Public title: Does an innovative method of sequencing, known as next generation sequencing (NGS), applied for normal embryo selection in infertile patients improve pregnancy rate in frozen transfer?
Scientific title: In patients with fertility problems, does next generation sequencing-based preimplantation genetic diagnosis followed by frozen blastocyst embryo transfer, compared to group without preimplantation genetic diagnosis, improve pregnancy rate?
Date of first enrolment: 01/08/2013
Target sample size: 114
Recruitment status: Active, not recruiting
URL:  https://anzctr.org.au/ACTRN12614001037695.aspx
Study type:  Interventional
Study design:  Purpose: Diagnosis; Allocation: Non-randomised trial; Masking: Open (masking not used);Assignment: Parallel;Type of endpoint: Efficacy;  
Phase:  Not Applicable
Countries of recruitment
Poland
Contacts
Name: Ms Judyta Zabielska   
Address:  Invicta Reproductive and Fertility Centres ul. Trzy lipy 3, 90-172, Gdansk Poland
Telephone: +48 516 829 691
Email: judytazabielska@gmail.com
Affiliation: 
Name: Ms Judyta Zabielska   
Address:  Invicta Reproductive and Fertility Centres ul. Trzy lipy 3, 90-172, Gdansk Poland
Telephone: +48 516 829 691
Email: judytazabielska@gmail.com
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Patients undergoing intracytoplasmic sperm injection (ICSI) in Invicta Fertility and Reproductive Centre s. z o.o. in time frame from 08.2013 to 01.2014
2. At least two previous implantation failures

Exclusion criteria: 1. Patients with endometriosis or adenomiosis
2. Patients with problems related to endometrium thickness


Age minimum: 33 Years
Age maximum: 39 Years
Gender: Both males and females
Health Condition(s) or Problem(s) studied
Reproductive Health and Childbirth - Fertility including in vitro fertilisation
fertlility problems;
fertlility problems
Intervention(s)
Preimplantation genetic diagnosis using next generation sequencing. Involves patient's biopsied embryos genetic analysis. Choice of the embryos for transfer was based on the PGD NGS results.
Duration: 12 hours of analysis
Frequency: Once in this investigation
Primary Outcome(s)
pregnancy rate (as ultrasound fetal heartbeat detection)[on 6 weeks and 1-3 days post embryo transfer]
Secondary Outcome(s)
miscarriage rate (ultrasound)[up to 12 weeks post embryo transfer]
implantation rate (by transvaginal ultrasound)[5 weeks and 3 days +/- 2 days post embryo transfer]
Secondary ID(s)
None
Source(s) of Monetary Support
Invicta s. z o.o.
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date:
Contact:
Komisja Bioetyczna przy Okregowej Izbie Lekarskiej
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history